| Monday June 9 |
||
| 08.00 | New developments in carotid stenting | |
| Moderators: K. Mathias, N. Hopkins, A. Halliday |
||
| 08.00 | Endovascular treatment of carotid artery occlusion in acute stroke, K. Mathias | |
| 08.07 | Stenting of carotid dissection at the acute phase, E. Houdart  |
|
| 08.14 | Carotid stenting in subtotal carotid stenosis, I. Petrov |
|
| 08.21 | OCT evaluation of micromesh carotid stent, J. Lemoine |
|
| 08.28 | CAS 2014: where are we for symptomatic patients? N. Hopkins | |
| 08.35 | CAS 2014: where are we for asymptomatic patients? A. Halliday | |
| 08.42 | Simultaneous bilateral carotid artery stenting vs unilateral carotid artery stenting: early and long-term results, X. Jiang |
|
| 08.49 | Why asymptomatic carotid stenosis should be treated, C. Buckley | |
| 08.56 | Flow reversal for carotid protection in difficult cases : tips and tricks, P. Montorsi |
|
| 09.03 | Discussion |
| 09.12 | Case reports and videos with MCQ  |
|||
| 09.12 | A new area for CAS with a novel stent, M. Amor | |||
| 09.19 | A safe cervical access for CAS using US guidance and closing device, P. Bergeron | |||
| 09.26 | A Silk Road case, N. Hopkins | |||
| 09.33 | Discussion | |||
| 09.45 | Industry sponsored symposium |
||
| 10.30 | Coffee break in the exhibition hall  |
||
| 11.00 | EVAR challenges: follow-up, endoleaks and complications | |||
| Moderators: I. van Herzeele, S. Ronchey, Z. Krajcer | ||||
| 11.00 | Debate | |||
| 11.00 | If you don’t have an effective follow-up program, don’t do EVAR, M. Thompson | |||
| 11.07 | Not every EVAR patient needs strict follow-up, R. McWilliams | |||
| 11.14 | Vote & discussion | |||
| 11.20 | Iliac endograft thrombosis after EVAR, A. Mansilha |
|||
| 11.27 | Enlargement of the proximal neck, P. Cao, C. Ferrer |
|||
| 11.34 | How do I treat type I endoleaks? | |||
| 11.34 | FEVAR, T. Resch |
|||
| 11.41 | Endoanchors are the way forward, J-P. De Vries | |||
| 11.48 | Chimps, Z. Rancic |
|||
| 11.55 | Vote & discussion | |||
| 12.02 | Treatment of the type II endoleaks, J. Van Den Berg |
|||
| 12.09 | Why not prevent endoleaks before they become a frustrating problem?, C. Buckley | |||
| 12.16 | EVAS: initial experience with NELLIX, J-M. Alsac |
|||
| 12.23 | Late results of secondary interventions for endoleaks, F. Verzini |
|||
| 12.30 | Intentional occlusion of fenestrations and sidebranches for endoleak treatment: incidence, underlying reasons and techniques, J. Tessarek |
|||
| 12.37 | Rescue EVAR for ruptured AAA: clinical success doesn’t mean technical success, F. Setacci |
|||
| 12.44 | Discussion | |||
| 12.48 | Infected stent-grafts | |||
| 12.48 | PET-CT in the follow-up of EVAR-treated AAA complicated by aorto-duodenal fistula, N. Sakalihasan |
|||
| 12.55 | Conservative, endovascular relining or conversion, L. Chiche |
|||
| 13.02 | Discussion | |||
| 13.15 | Lunch break  |
|||
| 14.15 | Industry sponsored session | ePosters competition session | |
| Jury: I. Van Herzeele, S. Ronchey | |||
| 16.00 | Coffee break in the exhibition hall |
||
| 16.30 | Industry sponsored symposium | ||
| 17.15 | Renal artery stenosis and denervation | ||
| Moderators: H. Benamer, M. Amor, X. Jiang | |||
| 17.15 | What is the place today of renal angioplasty, A. Sauguet | ||
| 17.25 | Rational for the renal denervation in resistant hypertension, A. Pathak |
||
| 17.35 | Results and a French experience of renal denervation in resistant hypertension, H. Benamer | ||
| 17.45 | Anatomic datas in renal denervation, M. Amor | ||
| 17.55 | Simple to complex renal denervation cases, H. Benamer | ||
| 18.05 | Discussion | ||
| 18.10 | Honorary guests lectures | ||
| 18.10 | The Pioneers in endovascular area: what did they all have in common? E. Diethrich | ||
| 18.30 | State of the art on carotid aneurysm, Z. Krajcer |
||
| 18.50 | End of the sessions | ||
| 20.00 | Official dinner | ||
